These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

938 related articles for article (PubMed ID: 9881643)

  • 21. Salt concentration determines 1,25-dihydroxyvitamin D3 dependency of vitamin D receptor-retinoid X receptor--vitamin D-responsive element complex formation.
    Kimmel-Jehan C; Jehan F; DeLuca HF
    Arch Biochem Biophys; 1997 May; 341(1):75-80. PubMed ID: 9143355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter.
    Sinkkonen L; Malinen M; Saavalainen K; Väisänen S; Carlberg C
    Nucleic Acids Res; 2005; 33(8):2440-51. PubMed ID: 15863722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 3-epi- and 24-oxo-derivatives of 1alpha,25 dihydroxyvitamin D(3) stimulate transcription through the vitamin D receptor.
    Messerlian S; Gao X; St-Arnaud R
    J Steroid Biochem Mol Biol; 2000; 72(1-2):29-34. PubMed ID: 10731635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological activities of 2alpha-substituted analogues of 1alpha,25-dihydroxyvitamin D3 in transcriptional regulation and human promyelocytic leukemia (HL-60) cell proliferation and differentiation.
    Takahashi E; Nakagawa K; Suhara Y; Kittaka A; Nihei K; Konno K; Takayama H; Ozono K; Okano T
    Biol Pharm Bull; 2006 Nov; 29(11):2246-50. PubMed ID: 17077522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro binding of vitamin D receptor occupied by 24R,25-dihydroxyvitamin D3 to vitamin D responsive element of human osteocalcin gene.
    Uchida M; Ozonco K; Pike JW
    J Steroid Biochem Mol Biol; 1997 Feb; 60(3-4):181-7. PubMed ID: 9191975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression.
    Sasaki H; Harada H; Handa Y; Morino H; Suzawa M; Shimpo E; Katsumata T; Masuhiro Y; Matsuda K; Ebihara K
    Biochemistry; 1995 Jan; 34(1):370-7. PubMed ID: 7819220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological activity of CD-ring modified 1alpha,25-dihydroxyvitamin D analogues: C-ring and five-membered D-ring analogues.
    Verstuyf A; Verlinden L; van Etten E; Shi L; Wu Y; D'Halleweyn C; Van Haver D; Zhu GD; Chen YJ; Zhou X; Haussler MR; De Clercq P; Vandewalle M; Van Baelen H; Mathieu C; Bouillon R
    J Bone Miner Res; 2000 Feb; 15(2):237-52. PubMed ID: 10703925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1alpha,25-Dihydroxyvitamin D(3)-26,23-lactam analogues function as vitamin D receptor antagonists in human and rodent cells.
    Ishizuka S; Kurihara N; Hiruma Y; Miura D; Namekawa J; Tamura A; Kato-Nakamura Y; Nakano Y; Takenouchi K; Hashimoto Y; Nagasawa K; Roodman GD
    J Steroid Biochem Mol Biol; 2008 Jun; 110(3-5):269-77. PubMed ID: 18501591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
    Chow EC; Quach HP; Vieth R; Pang KS
    Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the 1,25-dihydroxyvitamin D3-induced increase in vitamin D receptor (VDR) levels and binding of VDR-retinoid X receptor (RXR) to a direct repeat (DR)-3 type response element by an RXR-specific ligand in human keratinocyte cultures.
    Jensen TJ; Henriksen LO; Sølvsten H; Kragballe K
    Biochem Pharmacol; 1998 Mar; 55(6):767-73. PubMed ID: 9586948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct repeat 3-type element lacking the ability to bind to the vitamin D receptor enhances the function of a vitamin D-responsive element.
    Ozono K; Yamagata M; Ohyama Y; Nakajima S
    J Steroid Biochem Mol Biol; 1998 Sep; 66(5-6):263-9. PubMed ID: 9749832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
    Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
    Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
    Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The retinoid X receptor agonist 9-cis-retinoic acid and the 24-hydroxylase inhibitor ketoconazole increase activity of 1,25-dihydroxyvitamin D3 in human skin in vivo.
    Kang S; Li XY; Duell EA; Voorhees JJ
    J Invest Dermatol; 1997 Apr; 108(4):513-8. PubMed ID: 9077483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-proliferative activity of 25-hydroxyvitamin D3 in human prostate cells.
    Munetsuna E; Kawanami R; Nishikawa M; Ikeda S; Nakabayashi S; Yasuda K; Ohta M; Kamakura M; Ikushiro S; Sakaki T
    Mol Cell Endocrinol; 2014 Feb; 382(2):960-70. PubMed ID: 24291609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
    Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
    Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Previtamin D3 with a trans-fused decalin CD-ring has pronounced genomic activity.
    Verlinden L; Verstuyf A; Verboven C; Eelen G; De Ranter C; Gao LJ; Chen YJ; Murad I; Choi M; Yamamoto K; Yamada S; Van Haver D; Vandewalle M; De Clercq PJ; Bouillon R
    J Biol Chem; 2003 Sep; 278(37):35476-82. PubMed ID: 12829710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of 'non-calcaemic' vitamin D analogues on 24-hydroxylase expression in MG-63 osteoblast-like cells.
    Schroeder NJ; Burrin JM; Noonan K; Makin HL; Cunningham J
    Nephron Physiol; 2003; 94(4):p62-73. PubMed ID: 12972708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast.
    Kephart DD; Walfish PG; DeLuca H; Butt TR
    Mol Endocrinol; 1996 Apr; 10(4):408-19. PubMed ID: 8721985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.